SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-22-000066
Filing Date
2022-08-15
Accepted
2022-08-15 17:01:24
Documents
74
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20220630.htm   iXBRL 10-Q 1369302
2 EX-10 ex101_angnx06302022-10xq.htm EX-10 35569
3 EX-31.1 ex311_angnx06302022-10xq.htm EX-31.1 10577
4 EX-31.2 ex312_angnx06302022-10xq.htm EX-31.2 10725
5 EX-32.1 ex321angn-06302022x10xq.htm EX-32.1 6120
6 EX-32.2 ex322_angnx06302022-10xq.htm EX-32.2 6181
  Complete submission text file 0001601485-22-000066.txt   6902169

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20220630.xsd EX-101.SCH 46403
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20220630_cal.xml EX-101.CAL 73865
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20220630_def.xml EX-101.DEF 252580
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20220630_lab.xml EX-101.LAB 636707
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20220630_pre.xml EX-101.PRE 411540
68 EXTRACTED XBRL INSTANCE DOCUMENT angn-20220630_htm.xml XML 1074878
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 221166489
SIC: 2834 Pharmaceutical Preparations